REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma-Nord Patika Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: PHARMA-NORD PATIKA Gyogyszereszeti Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Pharma-Nord Patika Bt. is based in Hungary, with the head office in Gonc. It operates in the Pharmacies and Drug Stores industry. The company was established on October 15, 1996. The total number of employees is currently 4 (2024). In 2023, the company reported a net sales revenue increase of 9.98%. Its’ total assets recorded a growth of 15.58%. Pharma-Nord Patika Bt.’s net profit margin increased by 1.87% in 2023.

Headquarters
Karolyi Gaspar utca 34.
Gonc; Borsod-Abauj-Zemplen; Postal Code: 3895

Contact Details: Purchase the Pharma-Nord Patika Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Pharma-Nord Patika Bt. report to view the information.
Outstanding Shares:
Purchase the Pharma-Nord Patika Bt. report to view the information.
Registered Capital:
Purchase the Pharma-Nord Patika Bt. report to view the information.
Financial Auditors:
Purchase the Pharma-Nord Patika Bt. report to view the information.
Incorporation Date:
October 15, 1996
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Viridis-Pharma Kft.
Company Performance
Financial values in the chart are available after Pharma-Nord Patika Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
9.98%
Total operating revenue
9.76%
Operating profit (EBIT)
20.65%
EBITDA
23.68%
Net Profit (Loss) for the Period
39.91%
Total assets
15.58%
Total equity
88.08%
Operating Profit Margin (ROS)
0.81%
Net Profit Margin
1.87%
Return on Equity (ROE)
-16.12%
Quick Ratio
0.33%
Cash Ratio
0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?